T1	CHEM 32 39	morfina
#1	AnnotatorNotes T1	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T2	CHEM 47 59	hidromorfona
#2	AnnotatorNotes T2	C0012306; hydromorphone; Organic Chemical · Pharmacologic Substance
T3	PROC 1335 1357	escala verbal numérica
#3	AnnotatorNotes T3	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
T4	CHEM 100 111	bupivacaína
#4	AnnotatorNotes T4	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T5	PROC 142 180	ensayo ciego, con asignación aleatoria
#5	AnnotatorNotes T5	C0150108; Blinded; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T6	DISO 218 234	efectos adversos
#6	AnnotatorNotes T6	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T7	DISO 236 243	prurito
#7	AnnotatorNotes T7	C0033774; Pruritus; Sign or Symptom
T8	DISO 245 263	retención urinaria
#8	AnnotatorNotes T8	C0080274; Urinary Retention; Finding
T9	DISO 265 272	náuseas
#9	AnnotatorNotes T9	C0027497; Nausea; Sign or Symptom
T10	DISO 274 280	vómito
#10	AnnotatorNotes T10	C0042963; Vomiting; Sign or Symptom
T11	DISO 282 290	sedación
#11	AnnotatorNotes T11	C0235195; Sedated state; Finding
T12	CHEM 323 335	hidromorfona
#12	AnnotatorNotes T12	C0012306; hydromorphone; Organic Chemical · Pharmacologic Substance
T13	CHEM 338 345	morfina
#13	AnnotatorNotes T13	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T14	PROC 396 443	ensayo clínico prospectivo, aleatorizado, ciego
#14	AnnotatorNotes T14	C0150108; Blinded; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity + C0033522; Prospective Studies; Research Activity
T15	DISO 463 479	efectos adversos
#15	AnnotatorNotes T15	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T16	CHEM 511 518	morfina
#16	AnnotatorNotes T16	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T17	CHEM 524 536	hidromorfona
#17	AnnotatorNotes T17	C0012306; hydromorphone; Organic Chemical · Pharmacologic Substance
T18	CHEM 571 582	bupivacaína
#18	AnnotatorNotes T18	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T19	PROC 631 644	cirugía mayor
#19	AnnotatorNotes T19	C0679637; major surgery; Therapeutic or Preventive Procedure
T20	CHEM 687 699	hidromorfona
#20	AnnotatorNotes T20	C0012306; hydromorphone; Organic Chemical · Pharmacologic Substance
T21	CHEM 713 724	bupivacaína
#21	AnnotatorNotes T21	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T22	CHEM 749 756	morfina
#22	AnnotatorNotes T22	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T23	CHEM 770 781	bupivacaína
#23	AnnotatorNotes T23	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T24	DISO 879 895	efectos adversos
#24	AnnotatorNotes T24	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T25	DISO 996 1012	efectos adversos
#25	AnnotatorNotes T25	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T26	DISO 1071 1078	náuseas
#26	AnnotatorNotes T26	C0027497; Nausea; Sign or Symptom
T27	DISO 1103 1109	vómito
#27	AnnotatorNotes T27	C0042963; Vomiting; Sign or Symptom
T28	DISO 1136 1144	sedación
#28	AnnotatorNotes T28	C0235195; Sedated state; Finding
T29	DISO 1171 1189	retención urinaria
#29	AnnotatorNotes T29	C0080274; Urinary Retention; Finding
T30	DISO 1213 1220	prurito
#30	AnnotatorNotes T30	C0033774; Pruritus; Sign or Symptom
T31	CHEM 1621 1628	morfina
#31	AnnotatorNotes T31	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T32	CHEM 1644 1656	hidromorfona
#32	AnnotatorNotes T32	C0012306; hydromorphone; Organic Chemical · Pharmacologic Substance
T33	CHEM 1705 1716	bupivacaína
#33	AnnotatorNotes T33	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T34	PROC 1730 1748	analgesia epidural
#34	AnnotatorNotes T34	C0002769; Analgesia, Epidural; Therapeutic or Preventive Procedure
T35	CHEM 1771 1779	opiáceos
#35	AnnotatorNotes T35	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T36	PROC 1788 1797	analgesia
#36	AnnotatorNotes T36	C3202977; Analgesia; Therapeutic or Preventive Procedure
T37	PROC 63 81	analgesia epidural
#37	AnnotatorNotes T37	C0002769; Analgesia, Epidural; Therapeutic or Preventive Procedure
T38	ANAT 255 263	urinaria
#38	AnnotatorNotes T38	C0042036; Urine; Body Substance
T39	PROC 352 370	analgesia epidural
#39	AnnotatorNotes T39	C0002769; Analgesia, Epidural; Therapeutic or Preventive Procedure
T40	ANAT 1181 1189	urinaria
#40	AnnotatorNotes T40	C0042036; Urine; Body Substance
T41	DISO 1385 1399	dolor dinámico
#41	AnnotatorNotes T41	C0240386; movement pain; Finding (?)
T42	DISO 1503 1518	dolor en reposo
#42	AnnotatorNotes T42	C0234253; Rest pain; Sign or Symptom
T43	Route 73 81	epidural
#43	AnnotatorNotes T43	C0592511; Epidural Route of Drug Administration; Functional Concept
T44	Time 82 95	posquirúrgica
#44	AnnotatorNotes T44	C0032790; Postoperative Period; Temporal Concept
T45	Route 362 370	epidural
#45	AnnotatorNotes T45	C0592511; Epidural Route of Drug Administration; Functional Concept
T46	Time 371 384	posoperatoria
#46	AnnotatorNotes T46	C0032790; Postoperative Period; Temporal Concept
T47	Route 587 599	vía epidural
#47	AnnotatorNotes T47	C0592511; Epidural Route of Drug Administration; Functional Concept
T48	LIVB 604 613	pacientes
#48	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 651 659	paciente
#49	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Dose 700 708	10 µg/mL
T51	Dose 725 732	al 0,1%
T52	Dose 757 765	30 µg/mL
T53	LIVB 805 814	pacientes
#50	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Duration 830 857	las 24 horas posoperatorias
T56	LIVB 927 936	pacientes
#51	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T58	Duration 1367 1379	las 24 horas
T61	Dose 1629 1638	30 µg /mL
T62	Dose 1657 1665	10 µg/mL
T63	Dose 1717 1724	al 0,1%
T64	Route 1740 1748	epidural
#52	AnnotatorNotes T64	C0592511; Epidural Route of Drug Administration; Functional Concept
T65	Time 1749 1762	posoperatoria
#53	AnnotatorNotes T65	C0032790; Postoperative Period; Temporal Concept
T55	Dose 782 786	0,1%
T57	Neg_cue 1573 1575	no
T59	CONC 1580 1591	diferencias
A1	Assertion T59 Negated
#54	AnnotatorNotes T59	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T57 Arg2:T59	
T60	CONC 1253 1264	diferencias
A2	Assertion T60 Negated
#55	AnnotatorNotes T60	C1705241; Delta (difference); Quantitative Concept
T66	Neg_cue 1245 1247	No
R2	Negation Arg1:T66 Arg2:T60	
T67	Neg_cue 1519 1526	tampoco
T68	CONC 1534 1544	diferencia
A3	Assertion T68 Negated
#56	AnnotatorNotes T68	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T67 Arg2:T68	
R4	Has_Route_or_Mode Arg1:T2 Arg2:T43	
R5	Has_Route_or_Mode Arg1:T1 Arg2:T43	
R6	Used_for Arg1:T2 Arg2:T37	
R7	Used_for Arg1:T1 Arg2:T37	
R8	Overlap Arg1:T2 Arg2:T44	
R9	Overlap Arg1:T1 Arg2:T44	
R10	Location_of Arg1:T38 Arg2:T8	
R11	Has_Route_or_Mode Arg1:T12 Arg2:T45	
R12	Has_Route_or_Mode Arg1:T13 Arg2:T45	
R13	Used_for Arg1:T12 Arg2:T39	
R14	Used_for Arg1:T13 Arg2:T39	
R15	Overlap Arg1:T12 Arg2:T46	
R16	Overlap Arg1:T13 Arg2:T46	
R17	Causes Arg1:T12 Arg2:T6	
R18	Causes Arg1:T12 Arg2:T7	
R19	Causes Arg1:T12 Arg2:T8	
R20	Causes Arg1:T12 Arg2:T9	
R21	Causes Arg1:T12 Arg2:T10	
R22	Causes Arg1:T12 Arg2:T11	
R23	Causes Arg1:T13 Arg2:T6	
R24	Causes Arg1:T13 Arg2:T7	
R25	Causes Arg1:T13 Arg2:T8	
R26	Causes Arg1:T13 Arg2:T9	
R27	Causes Arg1:T13 Arg2:T10	
R28	Causes Arg1:T13 Arg2:T11	
R29	Causes Arg1:T16 Arg2:T15	
R30	Causes Arg1:T17 Arg2:T15	
R31	Combined_with Arg1:T16 Arg2:T18	
R32	Combined_with Arg1:T17 Arg2:T18	
R33	Has_Route_or_Mode Arg1:T18 Arg2:T47	
R34	Has_Route_or_Mode Arg1:T16 Arg2:T47	
R35	Has_Route_or_Mode Arg1:T17 Arg2:T47	
R36	Has_Route_or_Mode Arg1:T4 Arg2:T43	
R37	Combined_with Arg1:T1 Arg2:T4	
R38	Combined_with Arg1:T2 Arg2:T4	
R39	Before Arg1:T16 Arg2:T19	
R40	Before Arg1:T17 Arg2:T19	
R41	Experiences Arg1:T48 Arg2:T15	
R42	Experiences Arg1:T48 Arg2:T16	
R43	Experiences Arg1:T48 Arg2:T17	
R44	Experiences Arg1:T48 Arg2:T19	
R45	Experiences Arg1:T49 Arg2:T20	
R46	Combined_with Arg1:T20 Arg2:T21	
R47	Experiences Arg1:T49 Arg2:T22	
R48	Combined_with Arg1:T22 Arg2:T23	
R49	Has_Dose_or_Strength Arg1:T22 Arg2:T52	
R50	Has_Dose_or_Strength Arg1:T23 Arg2:T55	
R51	Has_Dose_or_Strength Arg1:T21 Arg2:T51	
R52	Has_Dose_or_Strength Arg1:T20 Arg2:T50	
T69	PROC 815 827	se evaluaron
#57	AnnotatorNotes T69	C1261322;Evaluation procedure; Health Care Activity
R53	Experiences Arg1:T53 Arg2:T69	
R54	Overlap Arg1:T69 Arg2:T54	
R55	Experiences Arg1:T53 Arg2:T24	
R56	Location_of Arg1:T40 Arg2:T29	
T70	Quantifier_or_Qualifier 1265 1296	estadísticamente significativas
A4	Assertion T70 Negated
#58	AnnotatorNotes T70	C0237881; Statistical Significance; Quantitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T70	
R58	Negation Arg1:T66 Arg2:T70	
R59	Overlap Arg1:T3 Arg2:T58	
R60	Overlap Arg1:T3 Arg2:T41	
T71	Quantifier_or_Qualifier 1545 1558	significativa
A5	Assertion T71 Negated
#59	AnnotatorNotes T71	C0237881; Statistical Significance; Quantitative Concept
R61	Has_Quantifier_or_Qualifier Arg1:T68 Arg2:T71	
R62	Negation Arg1:T67 Arg2:T71	
R63	Has_Dose_or_Strength Arg1:T31 Arg2:T61	
R64	Has_Dose_or_Strength Arg1:T32 Arg2:T62	
R65	Combined_with Arg1:T31 Arg2:T33	
R66	Combined_with Arg1:T32 Arg2:T33	
R67	Has_Dose_or_Strength Arg1:T33 Arg2:T63	
R68	Used_for Arg1:T31 Arg2:T34	
R69	Used_for Arg1:T32 Arg2:T34	
R70	Has_Route_or_Mode Arg1:T31 Arg2:T64	
R71	Has_Route_or_Mode Arg1:T32 Arg2:T64	
R72	Has_Route_or_Mode Arg1:T33 Arg2:T64	
R73	Overlap Arg1:T31 Arg2:T65	
R74	Overlap Arg1:T32 Arg2:T65	
R75	Overlap Arg1:T33 Arg2:T65	
R76	Combined_with Arg1:T33 Arg2:T35	
R77	Used_for Arg1:T35 Arg2:T36	
R78	Overlap Arg1:T35 Arg2:T65	
T72	Quantifier_or_Qualifier 614 625	programados
#60	AnnotatorNotes T72	C0205539; Scheduled - procedure status; Qualitative Concept
R79	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T72	
R80	Overlap Arg1:T24 Arg2:T54	
A6	Experiencer T48 Patient
A7	Experiencer T49 Patient
A8	Experiencer T56 Patient
A9	Experiencer T53 Patient
